GoHealth (GOCO)
OTHER OTC:GOCO
Want to see GOCO full AI Analyst Report?
Top Page
GoHealth
(OTC:GOCO)
Select Model
Select Model
Rating:39Underperform
Price Target:
$0.32
▼(-76.64% Downside)
Action:Reiterated
Date:06/17/26
The score is driven down primarily by very weak financial performance (sharp revenue decline, extreme losses, high leverage from near-depleted equity, and sizable cash burn) and significant bankruptcy/delisting corporate events that increase the risk of severe dilution or cancellation for common shareholders. Technicals are bearish (price below key moving averages) despite oversold signals, and valuation metrics provide limited support due to negative earnings and no dividend yield provided.
Positive Factors
Medicare-focused distribution and tech-enabled platform
GoHealth’s core focus on Medicare distribution and a tech-enabled, agent-assisted marketplace is a durable structural advantage: aging demographics support persistent demand for Medicare products, and the platform + licensed-agent model creates repeatable enrollment flow and carrier relationships that can sustain revenue through enrollment cycles.
Negative Factors
Sharp revenue decline and extreme operating losses
A sustained ~58% revenue decline and deeply negative margins indicate structural demand or execution problems that erode the company's ability to fund operations organically. Prolonged losses can impair agent capacity, marketing effectiveness, carrier partnerships, and the firm's ability to retain recurring renewal revenue.
Read all positive and negative factors
Positive Factors
Negative Factors
Medicare-focused distribution and tech-enabled platform
GoHealth’s core focus on Medicare distribution and a tech-enabled, agent-assisted marketplace is a durable structural advantage: aging demographics support persistent demand for Medicare products, and the platform + licensed-agent model creates repeatable enrollment flow and carrier relationships that can sustain revenue through enrollment cycles.
Read all positive factors
GoHealth (GOCO) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$9.96M
Dividend YieldN/A
Average Volume (3M)54.81K
Price to Earnings (P/E)―
Beta (1Y)0.69
Revenue Growth-81.69%
EPS Growth-9884.70%
CountryUS
Employees2,261
SectorFinancial
Sector Strength70
IndustryInsurance - Brokers
Share Statistics
EPS (TTM)-23.06
Shares Outstanding16,686,419
10 Day Avg. Volume90,134
30 Day Avg. Volume54,809
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.29
Price to Sales (P/S)0.08
P/FCF Ratio-0.21
Enterprise Value/Market Cap71.80
Enterprise Value/Revenue4.68
Enterprise Value/Gross Profit7.39
Enterprise Value/Ebitda-1.78
Forecast
1Y Price Target
$1.50Price Target Upside9.49% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)-7.26
Revenue Forecast (FY)$257.00M
GoHealth Business Overview & Revenue Model
Company Description
GoHealth, Inc. functions as a prominent digital health enterprise and health insurance marketplace operating across the United States, with a significant focus on Medicare products. Its business is strategically structured into four main divisions...
How the Company Makes Money
GoHealth primarily makes money by acting as a sales and distribution partner for health insurance carriers and earning commissions tied to successful enrollments. The company’s main revenue stream is carrier-paid commissions for Medicare-related e...
GoHealth Earnings Call Summary
Earnings Call Date:Nov 13, 2025
(Q3-2025)
| % Change Since: |
Next Earnings Date:Aug 06, 2026
Earnings Call Sentiment Neutral
The earnings call reflects a strategic shift by GoHealth towards focusing on retention, quality, and strategic flexibility amid challenging health plan economics. The company is investing in technology and positioning for industry consolidation, but faces challenges with reduced Medicare Advantage volume and tight cash management.Positive Updates
Focus on Strategic Flexibility and Retention
GoHealth has shifted its focus to prioritize retention, quality over quantity, and cash preservation. The company has reduced overhead and invested in AI and automation to improve agent effectiveness and consumer experience.
Negative Updates
Reduction in Medicare Advantage Volume
The company has intentionally scaled back its Medicare Advantage activity in response to tightening health plan economics and reduced broker compensation.
Read all updates
Q3-2025 Updates
Positive
Negative
Focus on Strategic Flexibility and Retention
GoHealth has shifted its focus to prioritize retention, quality over quantity, and cash preservation. The company has reduced overhead and invested in AI and automation to improve agent effectiveness and consumer experience.
Read all positive updates
Company Guidance
During the GoHealth Third Quarter 2025 Earnings Conference Call, CEO Vijay Kumar Kotte outlined the company's strategic focus on maintaining quality over quantity, emphasizing retention, and preserving cash and strategic flexibility. Amidst tightening health plan economics, GoHealth intentionally scaled back Medicare Advantage (MA) volume in favor of retention-oriented strategies, prioritizing their GoHealthProtect platform. This decision aligns with health plans' current priorities, which favor stable member profiles and retention over broad expansion. By concentrating on high-quality member retention and strategic flexibility, GoHealth also aims to lead consolidation efforts in a fragmented broker landscape. The company maintains confidence in its platform's efficiency, backed by continued investment in AI and automation, and enhanced governance with a refreshed board and a new senior secured super-priority term loan facility to support strategic opportunities.GoHealth Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
22
Negative
Cash Flow
24
Negative
| Breakdown | Mar 2026 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 361.85M | 798.89M | 734.67M | 631.67M | 1.06B |
| Gross Profit | 265.72M | 668.28M | 575.71M | 444.00M | 823.08M |
| EBITDA | -333.66M | 173.71M | 24.10M | -211.55M | -393.21M |
| Net Income | -257.13M | -2.93M | -63.26M | -148.71M | -189.36M |
Balance Sheet | |||||
| Total Assets | 987.38M | 1.49B | 1.50B | 1.66B | 2.07B |
| Cash, Cash Equivalents and Short-Term Investments | 32.90M | 40.92M | 90.81M | 16.46M | 84.36M |
| Total Debt | 672.59M | 527.97M | 543.05M | 557.42M | 696.29M |
| Total Liabilities | 992.70M | 1.03B | 1.04B | 1.07B | 1.18B |
| Stockholders Equity | 94.76M | 294.80M | 280.32M | 318.06M | 353.10M |
Cash Flow | |||||
| Free Cash Flow | -130.19M | -35.34M | 95.41M | 47.39M | -318.81M |
| Operating Cash Flow | -121.95M | -21.61M | 109.14M | 60.90M | -299.01M |
| Investing Cash Flow | -8.25M | 3.81M | -13.73M | -13.51M | -19.80M |
| Financing Cash Flow | 122.00M | -32.03M | -21.11M | -115.05M | 259.09M |
GoHealth Technical Analysis
Negative
1.37
Price Trends
0.83
Negative
1.26
Negative
2.39
Negative
Market Momentum
-0.16
Positive
28.66
Positive
23.11
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GOCO, the sentiment is Negative. The current price of 1.37 is above the 20-day moving average (MA) of 0.53, above the 50-day MA of 0.83, and below the 200-day MA of 2.39, indicating a bearish trend. The MACD of -0.16 indicates Positive momentum. The RSI at 28.66 is Positive, neither overbought nor oversold. The STOCH value of 23.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GOCO.
GoHealth Risk Analysis
GoHealth disclosed 128 risk factors in its most recent earnings report. GoHealth reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
GoHealth Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
60 Neutral | $12.33M | -7.28 | 4.56% | ― | 19.30% | -17.56% | |
57 Neutral | $52.37M | 1.53 | 3.57% | ― | -4.28% | -1.93% | |
54 Neutral | $174.30M | 2.00 | 15.28% | ― | 10.29% | ― | |
39 Underperform | $9.96M | -0.02 | -135.15% | ― | -81.69% | -9884.70% |
* Financial Sector Average
GOCO
GoHealth
0.34
-5.21
-93.95%
EHTH
Ehealth
1.65
-2.35
-58.75%
HUIZ
Huize Holding
1.22
-0.89
-42.18%
SLQT
SelectQuote
0.99
-1.23
-55.50%
GoHealth Corporate Events
Delistings and Listing ChangesLegal Proceedings
GoHealth Faces Nasdaq Delisting Amid Chapter 11 Restructuring
Negative
Jun 11, 2026
On June 7, 2026, GoHealth, Inc. and certain subsidiaries filed voluntary petitions for Chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware to implement a prepackaged reorganization plan, moves that raised public interes...
Business Operations and StrategyExecutive/Board ChangesDelistings and Listing ChangesLegal ProceedingsShareholder Meetings
GoHealth Initiates Prepackaged Chapter 11 Restructuring Plan
Negative
Jun 8, 2026
On June 7, 2026, GoHealth, Inc. and certain subsidiaries filed voluntary, prepackaged Chapter 11 petitions in the U.S. Bankruptcy Court in Delaware to implement a restructuring plan that will transfer ownership to certain lenders, reinstate prefer...
Delistings and Listing ChangesRegulatory Filings and Compliance
GoHealth Faces Nasdaq Noncompliance, Delisting Risk Looms
Negative
Mar 20, 2026
On March 18, 2026, GoHealth disclosed that it received a notice from Nasdaq stating the company was no longer in compliance with listing standards requiring a minimum $35 million market value of listed securities, as well as alternative thresholds...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.